These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34313394)

  • 1. Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
    Pinal-Fernandez I; Pak K; Gil-Vila A; Baucells A; Plotz B; Casal-Dominguez M; Derfoul A; Martinez-Carretero MA; Selva-O'Callaghan A; Sabbagh S; Casciola-Rosen L; Albayda J; Paik J; Tiniakou E; Danoff SK; Lloyd TE; Miller FW; Rider LG; Christopher-Stine L; Mammen AL;
    Arthritis Rheumatol; 2022 Feb; 74(2):358-364. PubMed ID: 34313394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
    Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel myositis-associated antibody directed against cortactin.
    Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Vilardell-Tarrés M; Juarez C
    Autoimmun Rev; 2014 Oct; 13(10):1008-12. PubMed ID: 25182205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
    Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
    Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
    Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Mecoli CA; Casal-Dominguez M; Pak K; Hosono Y; Huapaya J; Huang W; Albayda J; Tiniakou E; Paik JJ; Johnson C; Danoff SK; Corse AM; Christopher-Stine L; Mammen AL
    Neurology; 2019 Nov; 93(19):e1768-e1777. PubMed ID: 31594859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
    Sabbagh SE; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Miller FW; Rider LG; Mammen AL; Christopher-Stine L;
    Clin Rheumatol; 2021 Oct; 40(10):4095-4100. PubMed ID: 33851273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
    Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
    Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
    Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
    Phuong TNT; Ngoc LNT; Rönnelid J; Padyukov L; Lundberg IE
    Int J Rheum Dis; 2021 May; 24(5):663-670. PubMed ID: 33788398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
    Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies.
    Ito M; Moriya C; Matsuyama K; Shu E; Hamaguchi Y; Seishima M
    Case Rep Dermatol; 2020; 12(2):92-97. PubMed ID: 32508616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.